• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

Intercell AG

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact
intercell

Intercell AG

IPO 2005
Visit Website
  • Austria
  • Vaccines for infectious diseases
  • Investment Period: 8 years
  • IPO, 2005

TVM Capital Managing Partner Helmut Schühsler served on the company board since inception and provided key strategic advice and related contacts that enabled Intercell to grow through the development of both internally developed and in-licensed products. In 2004, the company in-licensed a late-stage product to complement its early-stage pipeline and move closer to the market.

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact